A Phase 2b Dose-Ranging Efficacy and Safety Study of Tralokinumab in Adult Patients with Moderate to Severe Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 2, n. S1, p. S29, 2018. DOI: 10.25251/skin.2.supp.28. Disponível em: https://skin.dermsquared.com/skin/article/view/281. Acesso em: 8 jun. 2025.